Department of Radiology
Found 7 results
Filters: Author is Grkovski, Milan  [Clear All Filters]
2020
Smith BJ, Buatti JM, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, Gillies RJ, Goldgof D, Grkovski M, Hamarneh G et al..  2020.  Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer Images.. Tomography. 6(2):65-76.
2019
Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Fung AM, Pentlow KS et al..  2019.  Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.. J Nucl Med. 60(12):1794-1801.
2018
Nehmeh SA, Schwartz J, Grkovski M, Yeung I, Laymon CM, Muzi M, Humm JL.  2018.  Inter-operator variability in compartmental kinetic analysis of F-fluoromisonidazole dynamic PET.. Clin Imaging. 49:121-127.
2017
Beichel RR, Smith BJ, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, Gillies RJ, Goldgof D, Grkovski M, Hamarneh G et al..  2017.  Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.. Med Phys. 44(2):479-496.
Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA.  2017.  Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.. J Nucl Med. 58(6):911-919.
2016
Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.. J Nucl Med. 57(3):334-41.
Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Reproducibility of F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.. EJNMMI Res. 6(1):79.